- Home
- CELU vs SST Comparison
CELU vs SST Comparison
Compare CELU & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELU | SST |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | 123 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7M | 67.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CELU | SST |
|---|---|---|
| Price | $1.67 | $4.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 60.6K | 30.1K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $40,578,000.00 | ★ $289,784,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $2.90 |
| 52 Week High | $4.35 | $15.00 |
Technical Indicators
Market Signals| Indicator | CELU | SST |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 50.71 |
| Support Level | $1.62 | $4.10 |
| Resistance Level | $2.01 | $5.00 |
| Average True Range (ATR) | 0.12 | 0.45 |
| MACD | -0.01 | 0.19 |
| Stochastic Oscillator | 0.00 | 59.91 |
Price Performance
Historical ComparisonAbout CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.